University Hospital Salzburg Selects IntraOp® Mobetron

September 17, 2019

 

Renowned medical university will install IntraOp’s electron IORT technology to bring Image Guided Electron Therapy to Salzburg, Austria.

SUNNYVALE, Calif. – September 17, 2019 – IntraOp Medical Corporation announced today that University Hospital Salzburg (SALK) Austria  has purchased the IntraOp’s third generation Mobetron and advanced treatment planning software, to pursue implementing Image Guided Electron Therapy (IGET) for intraoperative radiation therapy (IORT) clinically.

The Paracelsus Medical University Hospital Salzburg has been a pioneering thought leader in IORT for more than 20 years. Professor Felix Sedlmayer, head of  radiation oncology and president of the International Society of IORT (ISIORT) said: “We consider Mobetron as a perfect platform for further development of our IORT program and to implement image guided 3D treatment planning.”

Prof. Sedlmayer is the Principal Investigator in the ongoing HIOB trial (Hypofractionated Whole-Breast Irradiation preceded by Intra-Operative Radiotherapy with Electrons as anticipated Boost). HIOB is the largest prospective multi-institutional trial studying the benefits of electron IORT in the treatment of breast cancer.

“We are delighted to be partnering with Professor Sedlmayer and the team at University Hospital Salzburg and providing the most advanced IORT technology available today.” said Derek T. DeScioli, Chief Executive Officer of IntraOp Medical Corporation. “Their institution has been a pioneer in IORT from the beginning, and we look forward to working with them to advance the research and technology to the next level of sophistication.”

IntraOp will be providing to University Hospital Salzburg its third generation Mobetron technology including automatic soft docking, Prelude® IORT Management system and Radiance® 3D treatment planning as well high density radiotranslucent applicators compatible with Image Guided Electron Therapy.